Peptide vaccines for hepatocellular carcinoma

Immunotherapy is a potentially attractive treatment option for patients with hepatocellular carcinoma (HCC). We have reported that glypican-3 (GPC3) is an ideal target for anticancer immunotherapy against HCC because its expression is specifically detected in > 80% of HCCs, even during the early...

Full description

Saved in:
Bibliographic Details
Main Authors: Nobuoka, Daisuke, Yoshikawa, Toshiaki, Sawada, Yu, Fujiwara, Toshiyoshi, Nakatsura, Tetsuya
Format: Artigo
Language:Inglês
Published: Landes Bioscience 2013
Subjects:
Commentary
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3667940/
https://ncbi.nlm.nih.gov/pubmed/23442593
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/hv.22473
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items